Correlation between key indicators of continuous glucose monitoring and the risk of diabetic foot
Xin-Qian Geng, Shun-Fang Chen, Fei-Ying Wang, Hui-Jun Yang, Yun-Li Zhao, Zhang-Rong Xu, Ying Yang
Xin-Qian Geng, Shun-Fang Chen, Fei-Ying Wang, Hui-Jun Yang, Department of Endocrinology, Affiliated Hospital of Yunnan University, Second People’s Hospital of Yunnan Province, Kunming 650021, Yunnan Province, China
Yun-Li Zhao, Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education and Yunnan Province, Yunnan University, Kunming 650500, Yunnan Province, China
Zhang-Rong Xu, The Diabetic Center of PLA, The Ninth Medical Center of PLA General Hospital (306th Hosp PLA), Beijing 100101, China
Ying Yang, Department of Endocrinology and Metabolism, Affiliated Hospital of Yunnan University, Second People’s Hospital of Yunnan Province, Kunming 650021, Yunnan Province, China
Co-first authors: Xin-Qian Geng and Shun-Fang Chen.
Co-corresponding authors: Ying Yang and Zhang-Rong Xu.
Author contributions: Geng XQ and Chen SF designed the study and performed the statistical analysis; Chen SF, Wang FY, and Yang HJ collected the data; Geng XQ wrote the manuscript; Zhao YL supervised the study and validated the analysis; Xu ZR and Yang Y were responsible for revising the manuscript for important intellectual content and final approval of the version of the article to be published. All authors have read and approved the final manuscript. Geng XQ and Chen SF are co-first authors. Both Geng XQ and Chen SF played key roles in all stages of the research, including study design, data collection, analysis, and manuscript writing. Their work was crucial to the success of the research. Therefore, the co-first authorship is established to acknowledge their equal contributions to these core research activities. Our study encompasses a broad spectrum of expertise, with Yang Y bringing a deep understanding of endocrinology and the intricacies of continuous glucose monitoring, while Xu ZR specializes in podiatry and the specific risks associated with diabetic foot complications. This dual authorship ensures that inquiries regarding either the metabolic aspects or the clinical implications of our findings are addressed by the most knowledgeable party. Furthermore, the complexity and breadth of our data analysis require the input of both authors to fully respond to methodological and result-oriented queries. By designating two co-corresponding authors, we can ensure that the peer review process and subsequent correspondence are efficient and that all editorial and reader concerns are met with comprehensive and detailed responses. We believe this approach not only recognizes the equal contributions of both authors but also underscores the cross-regional collaboration that is central to our research.
Supported by Yunnan Province Academician (Expert) Workstation Project, No. 202305AF150097; the Basic Research Program of Yunnan Province (Kunming Medical University Joint Special Project, No. 202101AY070001-276; the National Natural Science Foundation of China, No. 82160159; the Key Project Program of Yunnan Province (Kunming Medical University Joint Special Project), No. 202301AY070001-013; the Major Science and Technology Project of Yunnan Province, No. 202202AA100004; and the Double First-class University Construction Project of Yunnan University, No. CY22624106.
Institutional review board statement: All experimental protocols were approved by Ethics Committees of the Affiliated Hospital of Yunnan University in compliance with the Declaration of Helsinki (No. 2022220).
Informed consent statement: Written consent was obtained from every participant and/or their legal guardian(s).
Conflict-of-interest statement: The authors declare no conflicts of interest.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Data sharing statement: The datasets used and/or analyzed in this study are available from the corresponding author upon reasonable request.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
https://creativecommons.org/Licenses/by-nc/4.0/ Corresponding author: Ying Yang, PhD, Chief Doctor, Professor, Department of Endocrinology and Metabolism, Affiliated Hospital of Yunnan University, Second People’s Hospital of Yunnan Province, No. 176 Qingnian Road, Kunming 650021, Yunnan Province, China.
yangying2072@126.com
Received: July 18, 2024
Revised: November 9, 2024
Accepted: December 23, 2024
Published online: March 15, 2025
Processing time: 186 Days and 20.2 Hours
